Delineation of RAID1, the RACK1 interaction domain located within theunique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5

BMC Biochemistry

Volumn 3, Issue , 2002, Pages 1-11

  Bolger, Graeme B ^c,d   McCahill, Angela ^a   Yarwood, Stephen J ^a   Steele, Michael R ^c   Warwicker, Jim ^b   Houslay, Miles D ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cyclic AMP; Protein kinase C binding protein; Rolipram; Signaling scaffold

Indexed keywords

AMINO ACID; CYCLIC AMP PHOSPHODIESTERASE; PHOSPHODIESTERASE 4D5; PROTEIN KINASE C; RECEPTOR FOR ACTIVATED PROTEIN KINASE C 1; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CRADD PROTEIN; CRADD PROTEIN, HUMAN; CYCLIC AMP; GNB2L1 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; PDE4D PROTEIN, HUMAN; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; MOLECULAR MODEL; MUTAGENESIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN INTERACTION; AMINO ACID SEQUENCE; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

ANIMALIA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CERCOPITHECUS AETHIOPS; COS CELLS; CRADD SIGNALING ADAPTOR PROTEIN; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; GTP-BINDING PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PHOSPHORIC DIESTER HYDROLASES; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE;

EID: 34248333795     PISSN: 14712091     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2091-3-24     Document Type: Article

References (56)

1. Houslay MD, Milligan G: Tailoring cAMP signalling responses through isoform multiplicity. Trends in Biochemical Sciences 1997, 22:217-224
2. Kammer GM: The adenylate cyclase-cAMP-protein kinase pathway and regulation of the immune response. Immunology Today 1988, 9:222-229
3. Lerner A, Kim DH, Lee R: The cAMP signaling pathway as a therapeutic target in lymphoid malignancies. Leuk Lymphoma 2000, 37:39-51
4. Manganiello VC, Smith CJ, Degerman E, Vasta V, Tornqvist H, Belfrage P: Molecular mechanisms involved in the antilipolytic action of insulin: Phosphorylation and activation of a particulate adipocyte cAMP phosphodiesterase. Advances in Experimental Medicine and Biology 1991, 293:239-248
5. Murphy BJ, Scott JD: Functional anchoring of the cAMP-dependent protein kinase. Trends in Cardiovascular Medicine 1998, 8:89-95
6. Beavo JA: Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiological Reviews 1995, 75:725-748
7. Bolger G: Molecular Biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes. Cellular Signalling 1994, 6:851-859
8. Conti M, Jin SLC: The molecular Biology of cyclic nucleotide phosphodiesterases. Progress in Nucleic Acid Research 1999, 63:1-38
9. Dousa TP: Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int 1999, 55:29-62
10. Houslay MD, Sullivan M, Bolger GB: The multi-enzyme PDE4 cyclic AMP specific phosphodiesterase family: intracellular targeting, regulation and selective inhibition by compounds exerting anti-inflammatory and anti-depressant actions. Advances in Pharmacology 1998, 44:225-342
11. Manganiello VC, Murata T, Taira M, Belfrage P, Degerman E: Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Archives of Biochemistry and Biophysics 1995, 322:1-13
12. Manganiello VC, Taira M, Degerman E, Belfrage P: Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE 3 gene family). Cellular Signalling 1995, 7:445-455
13. Torphy TJ: Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 1998, 157:351-70
14. Souness JE, Rao S: Proposal for pharmacologically distinct conformers of PDE4. Cellular Signalling 1997, 9:227-236
15. Giembycz MA: Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here? Drugs 2000, 59:193-212
16. Beard MB, Olsen AE, Jones RE, Erdogan S, Houslay MD, Bolger GB: UCR1 and UCR2 Domains Unique to the cAMP-specific Phosphodiesterase (PDE4) Family Form a Discrete Module via Electrostatic Interactions. Journal of Biological Chemistry 2000, 275:10349-58
17. Hoffmann R, Wilkinson IR, McCallum JF, Engels P, Houslay MD: cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: Generation of a molecular model. Biochemical Journal 1998, 333:139-149
18. Sette C, Conti M: Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. Journal of Biological Chemistry 1996, 271:16526-16534
19. MacKenzie SJ, Baillie GS, McPhee I, Bolger GB, Houslay MD: ERK2 MAP kinase binding, phosphorylation and regulation of PDE4D cAMP specific phosphodiesterases: the involvement of C-terminal docking sites and N-terminal UCR regions. J. Biol. Chem. 2000, 275:16609-16617
20. Houslay MD: The N-terminal alternately spliced regions of PDE4A cAMP-specific phosphodiesterases determine intra-cellular targeting and regulation of catalytic activity. Biochemical Society Transactions 1996, 24:980-986
21. Pooley L, Shakur Y, Rena G, Houslay MD: Intracellular localisation of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in transfected human thyroid carcinoma FTC cell lines. Biochemical Journal 1997, 271:177-185
22. Shakur Y, Wilson M, Pooley L, Lobban M, Griffiths SL, Campbell AM, Beattie J, Daly C, Houslay MD: Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum. Biochemical Journal 1995, 306:801-809
23. Huston E, Pooley L, Julien J, Scotland G, McPhee I, Sullivan M, Bolger G, Houslay MD: The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species which exhibit distinct kinetics of inhibition by the anti-depressant rolipram. J. Biol. Chem. 1996, 271:31334-31344
24. Huston E, Beard M, McCallum F, Pyne NJ, Vandenabeele P, Scotland G, Houslay MD: The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3: consequences for altered intracellular distribution. J Biol Chem 2000, 275:28063-74
25. Bolger GB, Erdogan S, Jones RE, Loughney K, Scotland G, Hoffmann R, Wilkinson I, Farrell C, Houslay MD: Characterisation of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochemical Journal 1997, 328:539-548
26. Yarwood SJ, Steele MR, Scotland G, Houslay MD, Bolger GB: The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform. J Biol Chem 1999, 274:14909-17
27. Mochly-Rosen D, Khaner H, Lopez J: Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci U S A 1991, 88:3997-4000
28. Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D: Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins [published erratum appears in Proc Natl Acad Sci U S A 1995 Feb 28;92(5):2016]. Proc Natl Acad Sci U S A 1994, 91:839-43
29. Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D: Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins [published erratum appears in Proc Natl Acad Sci U S A 1995 Feb 28;92(5):2016]. Proc Natl Acad Sci U S A 1994, 91:839-43
30. Mochly-Rosen D, Smith BL, Chen CH, Disatnik MH, Ron D: Interaction of protein kinase C with RACK1, a receptor for activated C-kinase: a role in beta protein kinase C mediated signal transduction. Biochem Soc Trans 1995, 23:596-600
31. Rodriguez MM, Ron D, Touhara K, Chen CH, Mochly-Rosen D: RACK1, a protein kinase C anchoring protein, coordinates the binding of activated protein kinase C and select pleckstrin homology domains in vitro. Biochemistry 1999, 38:13787-94
32. Liliental J, Chang DD: RACK1, a receptor for activated protein kinase C, interacts with integrin beta subunit. J Biol Chem 1998, 273:2379-83
33. Geijsen N, Spaargaren M, Raaijmakers JA, Lammers JW, Koenderman L, Coffer PJ: Association of RACK1 and PKCbeta with the common beta-chain of the IL-5/IL-3/GM-CSF receptor. Oncogene 1999, 18:5126-30
34. Smith PR, de Jesus O, Turner D, Hollyoake M, Karstegl CE, Griffin BE, Karran L, Wang Y, Hayward SD, Farrell PJ: Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol 2000, 74:3082-92
35. Chang BY, Conroy KB, Machleder EM, Cartwright CA: RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of Src tyrosine kinases and growth of NIH 3T3 cells. Molecular & Cellular Biology 1998, 18:3245-3256
36. Sondek J, Bohm A, Lambright DG, Hamm HE, Sigler PB: Crystal structure of a G-protein beta gamma dimer at 2.1A resolution. Nature 1996, 379:369-74
37. Wall MA, Coleman DE, Lee E, Iniguez-Lluhi JA, Posner BA, Gilman AG, Sprang SR: The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell 1995, 83:1047-58
38. Csukai M, Chen CH, De Matteis MA, Mochly-Rosen D: The coatomer protein beta'-COP, a selective binding protein (RACK) for protein kinase Cepsilon. J Biol Chem 1997, 272:29200-6
39. Bolger G, Michaeli T, Martins T, St John T, Steiner B, Rodgers L, Riggs M, Wigler M, Ferguson K: A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Molecular and Cellular Biology 1993, 13:6558-6571
40. Yarwood SJ, Steele MR, Scotland G, Houslay MD, Bolger GB: The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform (eratum). J Biol Chem 2001, 276:6879
41. Monera OD, Zhou NE, Lavigne P, Kay CM, Hodges RS: Formation of parallel and antiparallel coiled-coils controlled by the relative positions of alanine residues in the hydrophobic core. J Biol Chem 1996, 271:3995-4001
42. Monera OD, Sonnichsen FD, Hicks L, Kay CM, Hodges RS: The relative positions of alanine residues in the hydrophobic core control the formation of two-stranded or four-stranded alpha-helical coiled-coils. Protein Eng 1996, 9:353-63
43. Zhou NE, Kay CM, Hodges RS: The net energetic contribution of interhelical electrostatic attractions to coiled-coil stability. Protein Eng 1994, 7:1365-72
44. Pellegrino S, Zhang S, Garritsen A, Simonds WF: The coiled-coil region of the G protein beta subunit. Mutational analysis of Ggamma and effector interactions. J Biol Chem 1997, 272:25360-6
45. Rost B: PHD: predicting one-dimensional protein structure by profile-based neural networks. Methods Enzymol 1996, 266:525-39
46. Lambright DG, Sondek J, Bohm A, Skiba NP, Hamm HE, Sigler PB: The 2.0 A crystal structure of a heterotrimeric G protein. Nature 1996, 379:311-9
47. Steele MR, McCahill A, Thompson DS, MacKenzie C, Isaacs NW, Houslay MD, Bolger GB: Identification of a surface on the 3-propeller protein RACK1 that interacts with the cAMP specific phosphodiesterase PDE4D5. Cell. Signal. 2001, 13:507-513
48. Sondek J, Siderovski DP: Ggamma-like (GGL) domains: new frontiers in G-protein signaling and beta-propeller scaffolding. Biochem Pharmacol 2001, 61:1329-37
49. Colledge M, Scott JD: AKAPs: From structure to function. Trends in Cell Biology 1999, 9:216-221
50. Rubin CS: A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. Biochimica et Biophysica Acta 1994, 1224:467-479
51. Kreis TE, Lodish HF: Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface. Cell 1986, 46:929-937
52. Beard MB, O'Connell JC, Bolger GB, Houslay MD: The unique N-terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains. FEBS Lett 1999, 460:173-7
53. Bolger GB: Molecular genetic approaches. I. Two-hybrid systems. Methods Mol Biol 1998, 88:101-31
54. Bradford M: Protein determination in biological samples. Analytical Biochemistry 1976, 72:248-254
55. Sali A, Blundell TL: Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993, 234:779-815
56. Guex N, Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18:2714-23